Company

Oncimmune® was founded in 2003 to commercialise technology developed in the laboratories of Professor John Robertson, a professor of surgery at Nottingham University. Research continues in the laboratory of Professor Roberston, while development of products is funded through Oncimmune®, Ltd.

The first product for a lung cancer early detection test has had a limited launch in the USA and the company plans to develop further tests to be used as aids for the early detection of breast and ovarian cancer. The company plans to follow these products with aids to the early detection and characterisation of all the major solid tumour cancers.

In December of 2005, the company secured a substantial round of private investment, ensuring its ability to develop, and if scientifically justified, market the initially targeted products.

In 2006 Oncimmune®(USA)LLC was formed with Anthony C Barnes as Chief Executive Officer.